CJASN's 2019 impact factor is 6.628, ranking it 5th out of 80 journals within Urology & Nephrology
In celebration of the new impact factor, the editorial team is pleased to highlight:
- The top five articles by citation
- The top five articles by usage
- The top five articles by Altmetric score
- The top five podcasts
Top Five Articles by Citation over the Last 12 Months
| Mitigating Risk of COVID-19 in Dialysis Facilities | Alan S. Kliger and Jeffrey Silberzweig |
| Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19 | Matthew A. Sparks, Andrew South, Paul Welling, et al. |
| COVID-19 and the Inpatient Dialysis Unit | Anna Burgner, T. Alp Ikizler and Jamie P. Dwyer |
| Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients | David S. Goldfarb, Judith A. Benstein, Olga Zhdanova, et al. |
| Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis | Junhua Li and Gang Xu |
Top Five Articles by Usage over the Last 12 Months
| Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration | Parta Hatamizadeh, Ashita Tolwani, and Paul Palevsky |
| Mitigating Risk of COVID-19 in Dialysis Facilities | Alan S. Kliger and Jeffrey Silberzweig |
| COVID-19 and the Inpatient Dialysis Unit | Anna Burgner, T. Alp Ikizler and Jamie P. Dwyer |
| COVID-19 in Patients with Kidney Disease | Maria Ajaimy and Michal L. Melamed |
| Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19 | Matthew A. Sparks, Andrew South, Paul Welling, et al. |
Top Five Articles by Altmetric Score over the Last 12 Months
| Precision in GFR Reporting | Vanessa Grubbs |
| Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease | Jiahua Li, Oltjon Albajrami, Min Zhuo, et al. |
| Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19 | Benjamin Bowe, Miao Cai, Yan Xie, et al. |
| Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD | Matthew F. Blum, Aditya Surapaneni, James D. Stewart, et al. |
| Nephrology Nomenclature: How to Accelerate Patient Anxiety, Suppress Engagement, and Mire the Advance of Medical Innovation | Paul T. Conway |
Top Five Podcasts over the Last 3 Months
| Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease | Nicholas Rhys Medjeral-Thomas, Christopher Lawrence, Marie Condon, et al. |
| Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression | Judith E. Heida, Ron T. Gansevoort, A. Lianne Messchendorp, et al. |
| Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria | Meg Jardine, Zien Zhou, Hiddo J. Lambers Heerspink, et al. |
| Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival | James H. Lan, Matthew Kadatz, Doris T. Chang, et al. |
| Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD | Matthew B. Lanktree, Elsa Guiard, Pedram Akbari, et al. |
Check out the rest of the podcasts released in 2021 and 2020 and learn about the most important advances in clinical and translational research in nephrology.